Global Coronary Stents Market 2022 - Industry Briefing
The global coronary stents market is expected to increase by USD 1.8 billion, at a compound annual growth rate (CAGR) of 4.3% from 2022 to 2028, according to the latest edition of the Global Coronary Stents Market Report.
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, biomaterial, end user, and region. The global market data on coronary stents can be segmented by product: bare metal stents (BMS), bioabsorbable stents (BAS), drug eluting stents (DES). Coronary stents market is further segmented by biomaterial: metallic biomaterials, natural biomaterials, polymeric biomaterials. Based on end user, the coronary stents market is segmented into: ambulatory surgical centers (ASCs), hospitals. On the basis of region, the coronary stents market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).
The global coronary stents market is highly competitive. Top players covered in Global Coronary Stents Market Study are Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corp., Sahajanand Medical Technologies Pvt Ltd, Shandong Blue Sail Plastic & Rubber Co. Ltd. (Biosensors International Group Ltd.), Terumo Corporation, Translumina Therapeutics LLP, Vascular Concepts Ltd.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook